PROMTO

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.

Active ingredients

The drug PROMTO contains one active pharmaceutical ingredient (API):

1	Rabeprazole UNII 3L36P16U4R - RABEPRAZOLE SODIUM
	Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump).
	Read more about Rabeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-6103	Tablet	Promto TAB 20 mg	Enteric-coated tablet	02/12/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC04	Rabeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	57911, 58509
NG	Registered Drug Product Database	A4-6103